These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25986825)

  • 41. Unimed to develop a new testosterone delivery system.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):38. PubMed ID: 11362799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Precocious puberty secondary to topical testosterone transfer: a case report.
    Cavender RK; Fairall M
    J Sex Med; 2011 Feb; 8(2):622-6. PubMed ID: 21114766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.
    Marbury T; Hamill E; Bachand R; Sebree T; Smith T
    Biopharm Drug Dispos; 2003 Apr; 24(3):115-20. PubMed ID: 12673669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical uses of testosterone.
    Etzel JV; Lin AY; Barber PG
    DICP; 1991 Dec; 25(12):1341-3. PubMed ID: 1815432
    [No Abstract]   [Full Text] [Related]  

  • 45. A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men.
    Helo S; Ellen J; Mechlin C; Feustel P; Grossman M; Ditkoff E; McCullough A
    J Sex Med; 2015 Aug; 12(8):1761-9. PubMed ID: 26176805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Letter: Testosterone suppositories DAK].
    Lindholm J
    Ugeskr Laeger; 1974 Jan; 136(3):162. PubMed ID: 4822284
    [No Abstract]   [Full Text] [Related]  

  • 47. [Between physiologic aging and dysfunction. How much testosterone does a man need?].
    Volkert R
    MMW Fortschr Med; 2005 Mar; 147(11):4-5. PubMed ID: 15803840
    [No Abstract]   [Full Text] [Related]  

  • 48. Re: Can Treatment of Nocturia Increase Testosterone Level in Men with Late Onset Hypogonadism?
    Griebling TL
    J Urol; 2015 Sep; 194(3):733. PubMed ID: 26292873
    [No Abstract]   [Full Text] [Related]  

  • 49. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.
    Schubert M; Minnemann T; Hübler D; Rouskova D; Christoph A; Oettel M; Ernst M; Mellinger U; Krone W; Jockenhövel F
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5429-34. PubMed ID: 15531493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral testosterone, a reappraisal.
    Daggett PR; Wheeler MJ; Nabarro JD
    Horm Res; 1978; 9(3):121-9. PubMed ID: 640576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypogonadal men treated with oral testosterone undecanoate.
    Sarris S; Swyer GI; Lawrence DM
    Acta Eur Fertil; 1977 Dec; 8(4):297-9. PubMed ID: 610314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re: Ebert T, Jockenhövel F, Morales A, Shabsigh R. The current status of therapy for symptomatic late onset hypogonadism with transdermal testosterone gel. Eur Urol 2005;47:137-46.
    Ponholzer A; Rauchenwald M; Madersbacher S
    Eur Urol; 2005 Jul; 48(1):170-1; author reply 171. PubMed ID: 15967269
    [No Abstract]   [Full Text] [Related]  

  • 53. Testosterone therapy in erectile dysfunction and hypogonadism.
    Shabsigh R
    J Sex Med; 2005 Nov; 2(6):785-92. PubMed ID: 16422803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testosterone deficiency in older men: a problem worth treating.
    McHenry Martin C
    Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testosterone Undecanoate-Schering AG.
    Drugs R D; 2004; 5(6):368-9. PubMed ID: 15563244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of male hypogonadism with testosterone enanthate.
    Snyder PJ; Lawrence DA
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1335-9. PubMed ID: 6777395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testosterone release rate and duration of action of testosterone pellet implants.
    Kelleher S; Howe C; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):420-8. PubMed ID: 15049955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnosis and treatment of hypogonadism in adult males].
    Köhn FM
    Hautarzt; 2004 Sep; 55(9):877-895; quiz 896-7. PubMed ID: 15484339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current topics in testosterone replacement of hypogonadal men.
    Nieschlag E
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.
    Meuleman EJ; Legros JJ; Bouloux PM; Johnson-Levonas AO; Kaspers MJ; Elbers JM; Geurts TB; Meehan AG;
    Aging Male; 2015; 18(3):157-63. PubMed ID: 26030346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.